Christian A Muller
Overview
Explore the profile of Christian A Muller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Beck A, Pelz P, Lorenz R, Charlet K, Geisel O, Heinz A, et al.
Eur Neuropsychopharmacol
. 2018 Sep;
28(11):1206-1216.
PMID: 30217552
Increased functional brain response towards alcohol-associated stimuli is a neural hallmark of alcohol dependence and a promising target for pharmacotherapy. For the first time, we assessed the effects of individually...
12.
Geisel O, Hellweg R, Wiedemann K, Muller C
Psychiatry Res
. 2018 Jul;
268:193-197.
PMID: 30041134
Leptin has been suggested to be involved in the pathophysiology of addictive disorders via modulation of mesolimbic reward pathways. Previous studies in patients with substance use disorders (alcohol, tobacco, cocaine)...
13.
Geisel O, Behnke J, Schneider M, Wernecke K, Muller C
Addict Behav Rep
. 2018 Mar;
4:51-57.
PMID: 29511724
Background: In the majority of patients with alcohol use disorder (AUD), the clinical course is characterized by multiple relapses to drinking, frequently preceded by intense craving for alcohol. The present...
14.
Geisel O, Schlemm L, Hellweg R, Wiedemann K, Muller C
Pharmacopsychiatry
. 2018 Jan;
52(1):32-37.
PMID: 29359279
Aims: Activity of the hypothalamic-pituitary-adrenocortical (HPA) axis has been reported to be affected in alcohol use disorder (AUD). It has been suggested that pharmacological relapse prevention in AUD might exert...
15.
Soyka M, Muller C
Expert Opin Pharmacother
. 2017 Jun;
18(12):1187-1199.
PMID: 28658981
Only a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the...
16.
Batra A, Muller C, Mann K, Heinz A
Dtsch Arztebl Int
. 2016 May;
113(17):301-10.
PMID: 27173413
Background: In Germany today, there are more than 1.8 million persons who are dependent on alcohol, and 1.6 million persons whose use of alcohol is harmful. The many complications of...
17.
Geisel O, Hellweg R, Muller C
Psychiatry Res
. 2016 Apr;
240:177-180.
PMID: 27107672
The neurotrophin brain-derived neurotrophic factor (BDNF) has been suggested to be involved in the development and maintenance of addictive and other psychiatric disorders. Also, interactions of γ-aminobutyric acid (GABA)-ergic compounds...
18.
Stickel A, Rohdemann M, Landes T, Engel K, Banas R, Heinz A, et al.
Subst Use Misuse
. 2016 Apr;
51(5):545-52.
PMID: 27050118
Background: Previous studies have reported changes in nutrition-related behaviors in alcohol-dependent patients after alcohol detoxification, but prospective studies assessing the effects of these changes on maintaining abstinence are lacking. Objectives:...
19.
Geisel O, Panneck P, Stickel A, Schneider M, Muller C
Front Psychiatry
. 2015 Jul;
6:69.
PMID: 26217238
Current research on Internet addiction (IA) reported moderate to high prevalence rates of IA and comorbid psychiatric symptoms in users of social networking sites (SNS) and online role-playing games. The...
20.
Muller C, Geisel O, Pelz P, Higl V, Kruger J, Stickel A, et al.
Eur Neuropsychopharmacol
. 2015 Jun;
25(8):1167-77.
PMID: 26048580
Previous randomized, placebo-controlled trials (RCTs) assessing the efficacy of the selective γ-aminobutyric acid (GABA)-B receptor agonist baclofen in the treatment of alcohol dependence have reported divergent results, possibly related to...